Assembly Biosciences, Inc.
ASMB
$26.74
$2.4810.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 71.10M | 72.30M | 37.19M | 33.25M | 32.15M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.10M | 72.30M | 37.19M | 33.25M | 32.15M |
| Cost of Revenue | 64.86M | 64.81M | 61.84M | 58.77M | 58.91M |
| Gross Profit | 6.24M | 7.49M | -24.65M | -25.52M | -26.75M |
| SG&A Expenses | 19.78M | 19.61M | 18.80M | 18.00M | 17.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.64M | 84.42M | 80.64M | 76.77M | 76.79M |
| Operating Income | -13.55M | -12.12M | -43.45M | -43.52M | -44.63M |
| Income Before Tax | -6.38M | -6.12M | -38.62M | -39.04M | -39.59M |
| Income Tax Expenses | -- | -- | -76.00K | -76.00K | 330.00K |
| Earnings from Continuing Operations | -6.38 | -6.12 | -38.55 | -38.96 | -39.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.38M | -6.12M | -38.55M | -38.96M | -39.92M |
| EBIT | -13.55M | -12.12M | -43.45M | -43.52M | -44.63M |
| EBITDA | -13.43M | -11.99M | -43.32M | -43.39M | -44.50M |
| EPS Basic | -1.29 | -1.93 | -4.81 | -5.60 | -6.25 |
| Normalized Basic EPS | -0.81 | -1.20 | -3.02 | -3.51 | -3.87 |
| EPS Diluted | -1.29 | -1.93 | -4.81 | -5.60 | -6.25 |
| Normalized Diluted EPS | -0.81 | -1.20 | -3.02 | -3.51 | -3.87 |
| Average Basic Shares Outstanding | 54.18M | 44.79M | 34.38M | 28.05M | 26.04M |
| Average Diluted Shares Outstanding | 54.18M | 44.79M | 34.38M | 28.05M | 26.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |